Skip to main content
Skip main navigationClose Drawer MenuOpen Drawer Menu

Durability of Pulmonary Vein Isolation Using Pulsed-Field Ablation: Results From the Multicenter EU-PORIA RegistryGET ACCESS

Catheter Ablation - Atrial Fibrillation

J Am Coll Cardiol EP, 10 (4) 698–708

Central Illustration



Pulsed-field ablation (PFA) is a novel nonthermal ablation technology with high procedural safety and efficiency for pulmonary vein isolation (PVI). Premarket data showed high PVI durability during mandatory remapping studies. Data on lesion durability in real-world patients with clinically indicated redo procedures are scarce.


This study sought to report PVI durability rates in patients undergoing a clinically indicated redo procedure after an index PVI using PFA.


Patients from 7 European centers undergoing an index PVI using PFA were included the EU-PORIA (European Real-world Outcomes With Pulsed Field Ablation in Patients With Symptomatic Atrial Fibrillation) registry. In patients with subsequent left atrial redo procedures due to arrhythmia recurrence, 3-dimensional electroanatomical maps were acquired. PVI durability was assessed on a per-vein and per-patient level, and sites of reconnections and predictors of lesion durability were identified.


Of 1,184 patients (62% paroxysmal atrial fibrillation) undergoing an index PVI using PFA, 272 (23%) had an arrhythmia recurrence. Of these, 144 (53%) underwent a left atrial redo procedure a median of 7 (Q1-Q3: 5-10) months after the first ablation. Three-dimensional electroanatomical maps identified 404 of 567 pulmonary veins (71%) with durable isolation. In 54 patients (38%), all pulmonary veins were durably isolated. Prior operator experience with cryoballoon ablation was associated with a higher PVI durability compared to operators with only point-by-point radiofrequency experience (76% vs 60%; P < 0.001). Neither the operators’ cumulative experience in atrial fibrillation ablation (≤5 vs >5 years) nor the size of the PFA device used (31 mm vs 35 mm) had an impact on subsequent lesion durability (both P > 0.50).


In 144 patients with arrhythmia recurrence after PFA PVI, durable isolation was observed in 71% of the pulmonary veins during the redo procedure, and 38% of all patients showed durable isolation of all veins.


  • 1. Metzner A., Kuck K.H., Chun J.K.R. "What we have learned: is pulmonary vein isolation still the cornerstone of atrial fibrillation ablation?"Europace . 2022;24:suppl 2: ii8-ii13.

    CrossrefMedlineGoogle Scholar
  • 2. He X., Chen Y., Zhou Y., Huang Y., He J. "One-year clinical outcome of pulmonary vein isolation using the second-generation cryoballoon: a meta-analysis". Pacing Clin Electrophysiol . 2016;39:2: 182-189.

    CrossrefMedlineGoogle Scholar
  • 3. Cheung C.C., Deyell M.W., MacLe L., et al. "Repeat atrial fibrillation ablation procedures in the CIRCA-DOSE study". Circ Arrhythm Electrophysiol . 2020;13:9: e008480.

    CrossrefGoogle Scholar
  • 4. Kuck K.-H., Albenque J.-P., Chun K.R.J., et al.FIRE AND ICE Investigators. "Repeat ablation for atrial fibrillation recurrence post cryoballoon or radiofrequency ablation in the FIRE AND ICE trial". Circ Arrhythm Electrophysiol . 2019;12:6: e007247.

    CrossrefGoogle Scholar
  • 5. Ekanem E., Reddy V.Y., Schmidt B., et al.MANIFEST-PF Cooperative. "Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)". Europace . 2022;24:8: 1256-1266.

    CrossrefMedlineGoogle Scholar
  • 6. Reddy V.Y., Neuzil P., Koruth J.S., et al. "Pulsed field ablation for pulmonary vein isolation in atrial fibrillation". J Am Coll Cardiol . 2019;74:3: 315-326.

    View ArticleGoogle Scholar
  • 7. Tohoku S., Chun K.R.J., Bordignon S., et al. "Findings from repeat ablation using high-density mapping after pulmonary vein isolation with pulsed field ablation". Europace . 2023;25:2: 433-440.

    CrossrefMedlineGoogle Scholar
  • 8. Ruwald M.H., Johannessen A., Hansen M.L., Haugdal M., Worck R., Hansen J. "Pulsed field ablation in real-world atrial fibrillation patients: clinical recurrence, operator learning curve and re-do procedural findings". J Interv Card Electrophysiol . 2023;66:8: 1837-1848.

    CrossrefMedlineGoogle Scholar
  • 9. Magni F.T., Scherr D., Manninger M., et al. "Electrophysiological findings during re-do procedures after single-shot pulmonary vein isolation for atrial fibrillation with pulsed field ablation". J Interv Card Electrophysiol . 2023;66:7: 1729-1737.

    CrossrefMedlineGoogle Scholar
  • 10. Schmidt B., Bordignon S., Neven K., et al. "European Real-World Outcomes With Pulsed Field Ablation in Patients With Symptomatic Atrial Fibrillation: lessons from the multi-centre EU-PORIA registry". Europace . 2023;25:7: euad185.

    CrossrefGoogle Scholar
  • 11. Sørensen S.K., Johannessen A., Worck R., Hansen M.L., Hansen J. "Radiofrequency Versus Cryoballoon Catheter Ablation for Paroxysmal Atrial Fibrillation: Durability of Pulmonary Vein Isolation and Effect on Atrial Fibrillation Burden: the RACE-AF randomized controlled trial". Circ Arrhythm Electrophysiol . 2021;14:5: e009573.

    CrossrefGoogle Scholar
  • 12. Reddy V.Y., Dukkipati S.R., Neuzil P., et al. "Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II". J Am Coll Cardiol EP . 2021;7:5: 614-627.

    Google Scholar
  • 13. Martins R.P., Galand V., Cesari O., et al. "The second generation cryoballoon has improved durable isolation of left but not right pulmonary veins: new insights from a multicentre study". Europace . 2018;20:7: 1115-1121.

    CrossrefMedlineGoogle Scholar
  • 14. Kueffer T., Stefanova A., Madaffari A., et al. "Pulmonary vein isolation durability and lesion regression in patients with recurrent arrhythmia after pulsed-field ablation". J Interv Card Electrophysiol . Published online July31, 2023.

    CrossrefGoogle Scholar
  • 15. Schmidt B., Bordignon S., Tohoku S., et al. "5S study: Safe and Simple Single Shot Pulmonary Vein Isolation With Pulsed Field Ablation Using Sedation". Circ Arrhythm Electrophysiol . 2022;15:6: e010817.

    CrossrefMedlineGoogle Scholar
  • 16. Huo Y., Gaspar T., Schönbauer R., Wójcik M., Fiedler L., Roithinger F.X., et al. "Low-voltage myocardium-guided ablation trial of persistent atrial fibrillation". NEJM Evid . 2022;1:11:

    CrossrefMedlineGoogle Scholar